Drug Trial Radar · NCT02790632
Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Last checked: Nov 19, 2026Latest source record: Jul 26, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
374
Planned (sponsor's estimate)
Start
Jul 2016
Primary completion
Jun 2018
Study completion Jun 2018
Sponsor
- Lead sponsor
- Edge Therapeutics IncIndustry
- Sponsor type
- Industry
- First posted
- Jun 6, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study compares EG-1962 to enteral nimodipine in the treatment of aneurysmal subarachnoid hemorrhage.
Conditions
- Subarachnoid Hemorrhage, Aneurysmal
Interventions
EG-1962 (nimodipine microparticles)Drug
Single intraventricular administration of EG-1962 via EVD and placebo capsules or tablets administered for up to 21 days
Enteral NimodipineDrug
Enteral Nimodipine capsules or tablets administered for up to 21 days and single intraventricular administration of saline via EVD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects with a favorable outcome measured on the Extended Glasgow Outcome Scale [Primary Efficacy Endpoint]Time frame: 90 Days
Locations
79 sites in 11 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Hospital
Birmingham, Alabama
Dignity Health; St. Joseph's Hospital and Medical Center
Phoenix, Arizona
University of California, San Francisco-Fresno
Fresno, California
Keck Hospital of USC
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
David Geffen School of Medicine at UCLA
Los Angeles, California
UCSF
San Francisco, California
Yale New Haven Hospital (YNHH)
New Haven, Connecticut
UF Health Shands Florida
Gainesville, Florida
Baptist Medical Center/Lyerly Neurosurgery
Jacksonville, Florida
Mayo Clinic Florida
Jacksonville, Florida
Tallahassee Neurological Clinic
Tallahassee, Florida
Northwestern Memorial Hospital
Chicago, Illinois
University of Illinois Hospital and Health Sciences System
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky Medical Center
Lexington, Kentucky
University of Louisville Hospital
Louisville, Kentucky
University of Maryland Medical Systems
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Hackensack University Medical Center
Hackensack, New Jersey
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
University of New Mexico Hospital
Albuquerque, New Mexico
North Shore University Hospital
Manhasset, New York
Icahn School of Medicine at Mount Sinai
New York, New York
Lenox Hill Hospital
New York, New York
University of Rochester Medical Center
Rochester, New York
Montefiore Medical Center
The Bronx, New York
UNC Hospitals Neuroscience Intensive Care Unit
Chapel Hill, North Carolina
Duke University Medical Pavilion
Durham, North Carolina
University Hospitals Case Medical Center
Cleveland, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
Providence St. Vincent Medical Center
Portland, Oregon
Oregon Health and Science University
Portland, Oregon
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Jefferson Hospital for Neuroscience
Philadelphia, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania
Showing 40 of 79 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.